Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sulodexide in the treatment of early stages of COVID-19: A randomised controlled trial

Trial Profile

Sulodexide in the treatment of early stages of COVID-19: A randomised controlled trial

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 30 Jan 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Sulodexide (Primary)
  • Indications COVID 2019 infections; Thrombosis
  • Focus Therapeutic Use
  • Acronyms ERSul
  • Most Recent Events

    • 14 Dec 2021 Results (N=312) of ITT population presented at the 63rd American Society of Hematology Annual Meeting and Exposition
    • 11 Mar 2021 New trial record
    • 07 Mar 2021 Primary endpoint (decreasing the need for both hospital admission and supplemental oxygen treatment) has been met as per results published in the Thrombosis and Haemostasis.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top